Following the Concentration of Polymeric Nanoparticles During Nebulization

被引:35
作者
Beck-Broichsitter, Moritz [1 ]
Knuedeler, Marie-Christine [1 ]
Schmehl, Thomas [1 ]
Seeger, Werner [1 ]
机构
[1] Univ Giessen, Dept Internal Med, Med Clin 2, D-35392 Giessen, Germany
关键词
aggregation; biodegradable nanoparticles; concentration changes; pulmonary drug delivery; vibrating-membrane nebulization; BIODEGRADABLE NANOPARTICLES; DRUG-DELIVERY; NANOTECHNOLOGY; PERFORMANCE; FORMULATION; DESIGN; IMPACT; NANO; JET;
D O I
10.1007/s11095-012-0819-0
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Nebulization represents one strategy to achieve pulmonary deposition of biodegradable nanoparticles. Besides stability as a key requirement to maintain functionality, the output of nanoparticles from the nebulizer needs to be considered to facilitate an efficient pulmonary therapy. Formulations nebulized by air-jet and vibrating-membrane technology were analyzed for their aerodynamic characteristics by laser diffraction. The nebulization stability of poly(D,L-lactide-co-glycolide) nanoparticles was assessed by dynamic light scattering. Moreover, several methods were employed to account for the shift in solute and NP reservoir concentration during nebulization. Regardless of the formulation or nebulizer used generated aerosols all showed aerodynamic characteristics suitable for deep lung deposition. However, nanoparticles were prone to aggregation and concentrated during air-jet nebulization. The particle concentration effect was significantly pronounced in comparison to molecular solutes under the same nebulization conditions, due to nanoparticle aggregation and subsequent particle remainder in the reservoir. In contrast, vibrating-membrane technology did not affect nanoparticle integrity and reservoir concentration during nebulization, as the unaffected submicron particles passed through the tapered holes of the actuated plate. Aggregation and concentration effects during air-jet nebulization emphasize that nanosuspensions should preferably be delivered with a suitable vibrating-membrane device in order to ensure an effective pulmonary application.
引用
收藏
页码:16 / 24
页数:9
相关论文
共 36 条
  • [1] Beck-Broichsitter M, 2011, J CONTROL RELEASE, DOI [10.1016/j.jconrel.2011.1012.1004, DOI 10.1016/J.JCONREL.2011.1012.1004]
  • [2] Characterization of novel spray-dried polymeric particles for controlled pulmonary drug delivery
    Beck-Broichsitter, Moritz
    Schweiger, Christoph
    Schmehl, Thomas
    Gessler, Tobias
    Seeger, Werner
    Kissel, Thomas
    [J]. JOURNAL OF CONTROLLED RELEASE, 2012, 158 (02) : 329 - 335
  • [3] Nebulization performance of biodegradable sildenafil-loaded nanoparticles using the Aeroneb® Pro: Formulation aspects and nanoparticle stability to nebulization
    Beck-Broichsitter, Moritz
    Kleimann, Pia
    Gessler, Tobias
    Seeger, Werner
    Kissel, Thomas
    Schmehl, Thomas
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2012, 422 (1-2) : 398 - 408
  • [4] Novel 'Nano in Nano' Composites for Sustained Drug Delivery: Biodegradable Nanoparticles Encapsulated into Nanofiber Non-Wovens
    Beck-Broichsitter, Moritz
    Thieme, Marcel
    Nguyen, Juliane
    Schmehl, Thomas
    Gessler, Tobias
    Seeger, Werner
    Agarwal, Seema
    Greiner, Andreas
    Kissel, Thomas
    [J]. MACROMOLECULAR BIOSCIENCE, 2010, 10 (12) : 1527 - 1535
  • [5] Preparation of nanoparticles by solvent displacement for drug delivery: A shift in the "ouzo region" upon drug loading
    Beck-Broichsitter, Moritz
    Rytting, Erik
    Lebhardt, Tobias
    Wang, Xiaoying
    Kissel, Thomas
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 41 (02) : 244 - 253
  • [6] Pulmonary Targeting with Biodegradable Salbutamol-Loaded Nanoparticles
    Beck-Broichsitter, Moritz
    Gauss, Julia
    Gessler, Tobias
    Seeger, Werner
    Kissel, Thomas
    Schmehl, Thomas
    [J]. JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2010, 23 (01) : 47 - 57
  • [7] Pulmonary drug delivery with aerosolizable nanoparticles in an ex vivo lung model
    Beck-Broichsitter, Moritz
    Gauss, Julia
    Packhaeuser, Claudia B.
    Lahnstein, Kerstin
    Schmehl, Thomas
    Seeger, Werner
    Kissel, Thomas
    Gessler, Tobias
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2009, 367 (1-2) : 169 - 178
  • [8] Influence of particle size on regional lung deposition - What evidence is there?
    Carvalho, Thiago C.
    Peters, Jay I.
    Williams, Robert O., III
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2011, 406 (1-2) : 1 - 10
  • [9] Particle engineering for pulmonary drug delivery
    Chow, Albert H. L.
    Tong, Henry H. Y.
    Chattopadhyay, Pratibhash
    Shekunov, Boris Y.
    [J]. PHARMACEUTICAL RESEARCH, 2007, 24 (03) : 411 - 437
  • [10] Nanotechnology: Intelligent design to treat complex disease
    Couvreur, Patrick
    Vauthier, Christine
    [J]. PHARMACEUTICAL RESEARCH, 2006, 23 (07) : 1417 - 1450